Mylan Gets More Sanofi Insulin Pen Patents Nixed At PTAB

Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins in cases related to the same product…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s